← Leaderboards
Qiaobing Xu
Tufts University Medford
$3,053,023
Attributed
$5,307,484
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2013–25$2M$1.5M$1M$500K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,307,484 · 5
By mechanism
UG3$2,402,907 · 1
R01$2,349,931 · 2
R21$407,259 · 1
R03$147,387 · 1
Top collaborators
- Zheng-Yi Chen3 shared
- David R Liu3 shared
- Yan Tang2 shared
Most similar at Tufts University Medford
Same institution · by research overlap
- Yamin Li$959,435
- Kyle Patrick Quinn$8,363,573
- Yan Tang$652,524
Others in their field
Top investigators on “In Vivo”
- David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Dennis R. Burton · Scripps Research Institute$212,708,174
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200
Research focus
In VivoFormulationIn VitroNanoparticleCellsBaseProteinsMouse ModelOrganBiologicalLipidsStructureCationsMediatingSuccessToxic EffectBiological ProcessLibrariesPublic Health RelevanceGenesDisulfide BondLipid NanoparticlePropertyModality
Grant awards (12)
Develop lung-targeted synthetic lipid nanoparticles for mRNA medicine treating pulmonary lymphangioleiomyomatosis$645,566
R01 · FY2025 · HL · contact PI
Develop lung-targeted synthetic lipid nanoparticles for mRNA medicine treating pulmonary lymphangioleiomyomatosis$659,481
R01 · FY2024 · HL · contact PI
ROS-responsive Chemical Modification of Protein and Its Delivery$348,007
R01 · FY2022 · EB · contact PI
Efficient in Vivo RNP-based Gene Editing in the Sensory Organ Inner Ear Using Bioreducible Lipid Nanoparticles$782,510
UG3 · FY2020 · TR
Efficient in Vivo RNP-based Gene Editing in the Sensory Organ Inner Ear Using Bioreducible Lipid Nanoparticles$789,370
UG3 · FY2019 · TR
ROS-responsive Chemical Modification of Protein and Its Delivery$348,356
R01 · FY2019 · EB · contact PI
Efficient in Vivo RNP-based Gene Editing in the Sensory Organ Inner Ear Using Bioreducible Lipid Nanoparticles$831,027
UG3 · FY2018 · TR
ROS-responsive Chemical Modification of Protein and Its Delivery$348,521
R01 · FY2018 · EB · contact PI
Engineer synthetic exosome for promoting axon growth$183,916
R21 · FY2018 · EB · contact PI
Engineer synthetic exosome for promoting axon growth$223,343
R21 · FY2017 · EB · contact PI
Fabrication and characterization of constructs from decellularized tendon$72,650
R03 · FY2014 · EB · contact PI
Fabrication and characterization of constructs from decellularized tendon$74,737
R03 · FY2013 · EB · contact PI